BioXcel Therapeutics

-$0.46 (-1.77%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BTAI and other ETFs, options, and stocks.

About BTAI

BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company, which focuses on drug development. The firm's two clinical development programs are BXCL501, a sublingual thin film formulation designed for acute treatment of agitation resulting from neurological and psychiatric disorders, and BXCL701, an immuno-oncology agent designed for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer.

CEO

Vimal D. Mehta

Employees

Headquarters

New Haven, Connecticut

Founded

2017

BTAI Key Statistics

Market Cap

927.94M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

346.19K

High Today

$26.09

Low Today

$25.01

Open Price

$26.07

Volume

240.98K

52 Week High

$67.74

52 Week Low

$23.79

Analyst Ratings

100%

of 9 ratings

Buy

100%

Hold

Sell

BTAI Earnings

-$1.08

-$0.72

-$0.36

$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Available Aug 10, Pre-Market